Monday, May 12, 2025
5/12/2025
Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation - Project Summary/Abstract The overarching goal of the proposed research is to elucidate the initiating mechanisms in the development of cancer-prone chronic inflammation for cancer prevention and therapy. Chronic inflammatory diseases, such as chronic dermatitis, pancreatitis, colitis and hepatitis, are major risk factors for cancer. In addition, a tumor- promoting immune environment, which resembles chronic inflammation, is a key driver of cancer development across the majority of cancer types. By studying the mediators of the transition from acute to chronic inflammation, we have demonstrated that interleukin (IL)-33 cytokine is a key initiator of chronic inflammation that eventually leads to cancer development in the skin, colon and pancreas. Importantly, we have recently discovered that the nuclear function of IL-33 within the epithelial cells plays an essential role in cancer development in chronic skin and pancreas inflammation. To develop an effective strategy to suppress cancer- prone chronic inflammation, we will focus on the mechanism that blocks the initiating steps in the development of a cancer-prone chronic inflammation. Founded on our innovative discovery that IL-33 is an essential initiator of cancer-prone chronic inflammation, we aim to determine the mechanism of IL-33 induction in tissues exposed to inflammatory insults and to develop a novel therapeutic approach to inhibit IL-33 expression for cancer prevention and therapy. To accomplish this, we will use novel mouse models and clinical samples to (1) determine the mechanism of IL-33 induction in chronic inflammation triggered by chemical agents, (2) investigate the role of IL-33 in cancer-prone chronic inflammation associated with a viral infection, and (3) study inhibitor of IL-33 that can block chronic inflammation and the subsequent cancer development. The outcomes of our research will establish a fundamental pathway to suppress chronic inflammation-associated cancer and provide the means to prevent cancer progression and recurrence.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).